GlassScriptPhysician profile
Bryan J Loeffler
NPI 1720118540
$44,123.12
in general payments reported to CMS, 2019-2025
20 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,912 · 2021: $1,758 · 2022: $2,275 · 2023: $4,472 · 2024: $1,638 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $4,257 · Travel and Lodging: $2,443 · Consulting Fee: $1,600 · Honoraria: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,250.00 |
| Food and Beverage | $4,256.76 |
| Travel and Lodging | $2,443.07 |
| Consulting Fee | $1,600.00 |
| Honoraria | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $15,096.05 | 2019 | |
| Arthrex, INC. | $12,966.99 | 2019-2025 | |
| Peerless Surgical INC. | $5,167.07 | 2019-2025 | |
| Checkpoint Surgical, INC | $4,890.85 | 2019-2024 | Checkpoint Stimulators |
| Axogen | $1,529.19 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Pharmaceutical Business Consultants Limited | $1,250.00 | 2023 | |
| Ossur Americas, INC. | $726.68 | 2024-2025 | I-Digits Quantum, I-Limb |
| Zimmer Biomet Holdings, INC. | $544.12 | 2019-2023 | Mymobility Platform |
| Stryker Corporation | $490.81 | 2021-2025 | Aequalis Perform Reversed, Pangea, Blueprint Patient Specific Instrumentation |
| Medacta USA, INC. | $251.18 | 2019-2025 | Primary Shoulder |
| Integra Lifesciences Corporation | $243.48 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $222.42 | 2024 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $192.12 | 2021-2024 | Na, Dynaforce |
| Acumed LLC | $173.99 | 2020-2024 | Inframe Implant, Arcphix System, Innate Implant |
| Integrity Orthopaedics, INC. | $144.53 | 2024 | Integrity Orthopaedics |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $115.93 | 2024 | Inset System |
| Endo Pharmaceuticals INC. | $87.47 | 2019-2022 | |
| Bioventus LLC | $17.42 | 2020 | |
| Medartis INC. | $12.82 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,116.93 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Loeffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.